B0T Stock Overview
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Promimic AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.96 |
| 52 Week High | SEK 3.44 |
| 52 Week Low | SEK 2.10 |
| Beta | 0.26 |
| 11 Month Change | 0.34% |
| 3 Month Change | 29.82% |
| 1 Year Change | 4.59% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 93.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| B0T | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -1.7% | 9.5% | -0.5% |
| 1Y | 4.6% | -12.3% | -0.3% |
Return vs Industry: B0T exceeded the German Life Sciences industry which returned -12.3% over the past year.
Return vs Market: B0T exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| B0T volatility | |
|---|---|
| B0T Average Weekly Movement | 8.9% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: B0T's share price has been volatile over the past 3 months.
Volatility Over Time: B0T's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 17 | Magnus Larsson | www.promimic.com |
Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. Promimic AB (publ) was incorporated in 2004 and is headquartered in Mölndal, Sweden.
Promimic AB (publ) Fundamentals Summary
| B0T fundamental statistics | |
|---|---|
| Market cap | €61.31m |
| Earnings (TTM) | -€802.55k |
| Revenue (TTM) | €3.60m |
17.0x
P/S Ratio-76.4x
P/E RatioIs B0T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B0T income statement (TTM) | |
|---|---|
| Revenue | SEK 42.03m |
| Cost of Revenue | SEK 815.00k |
| Gross Profit | SEK 41.21m |
| Other Expenses | SEK 50.59m |
| Earnings | -SEK 9.38m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 98.06% |
| Net Profit Margin | -22.32% |
| Debt/Equity Ratio | 0% |
How did B0T perform over the long term?
See historical performance and comparison